INTRODUCTION
Salmonella enterica is a Gram-negative and facultative intracellular bacterium that causes a broad spectrum of diseases, such as gastroenteritis, bacteraemia and typhoid fever. The nature and severity of infections by Salmonella are generally dependent upon both the serovar and the host species. Typhoid and paratyphoid fevers result from systemic infection with the human-adapted serovars S. enterica serovar Typhi and S. enterica serovar Paratyphi A. In contrast, infection with the broad-host-range-adapted S. enterica serovar Typhimurium usually causes gastroenteritis in humans, but produces a systemic infection similar to typhoid fever in susceptible mice. Among more than 2000 Salmonella serovars, S. enterica serovar Choleraesuis is one of the most important swine pathogens, and a frequent cause of serious systemic infections, including typhoid disease and pneumonia. Although S. enterica serovar Choleraesuis is highly host adapted, the bacterium is a frequent cause of systemic infections, such as bacteraemia, in humans (Blaser & Feldman, 1981; Cohen et al., 1987) .
The human complement system is an important effector system of the innate immunity in the first line of defence against invading micro-organisms (Joiner, 1988; Taylor, 1983) . The complement system is a complex system of serum proteins that can be activated by three different pathways: a classical pathway, a lectin pathway and an alternative pathway. Activation of the complement system by any of the three pathways leads to a number of biological consequences resulting in killing of invading bacteria. Both Gram-negative and -positive bacteria are opsonized with complement activation products C3b and iC3b, while the membrane attack complex (MAC) can be formed on Gram-negative organisms only. Although opsonophagocytosis is the major antibacterial defence mechanism by the complement system, the formation of the MAC has been shown to be necessary for killing of some Gramnegative bacteria (Joiner et al., 1986; Tomlinson et al., 1989) . Importantly, microbes that cause invasive infections have evolved a number of strategies to protect themselves against the bactericidal action of the complement (Joiner, 1988; Taylor, 1983) .
Structures of the bacterial cell surface, which include capsules, LPS and outer-membrane proteins, are responsible for the complement resistance of bacteria (Joiner, 1988; Rautemaa & Meri, 1999; Taylor, 1983) . In Salmonella, the presence of long O-antigen chains is required for resistance to the complement cascade (Grossman et al., 1990; Joiner et al., 1986; Murray et al., 2003; Tomas et al., 1988) . Other potential components of complement resistance have been identified in S. enterica serovar Typhimurium, including rck (Heffernan et al., 1992b) , rsk (Vandenbosch et al., 1989) and traT (Rhen & Sukupolvi, 1988) . The complement resistance mediated by Rck is associated with a failure to form fully polymerized tubular MACs on the bacterial surface membrane (Heffernan et al., 1992b) . The rsk region does not contain the coding sequence, but it appears to enhance the ability of S. enterica serovar Typhimurium to survive in human serum, perhaps by removing effector molecules which function to repress serum resistance (Vandenbosch et al., 1989) . The TraT lipoprotein of Salmonella and Escherichia coli increases the resistance of the bacteria to complement killing by interfering with the formation of C5b6, and the correct assembly and membrane insertion of the MAC (Pramoonjago et al., 1992) . These loci involved in the serum resistance phenotype are carried on the virulence plasmid of S. enterica serovar Typhimurium. However, S. enterica serovar Choleraesuis contains the traT and rsk loci, but not the rck gene, on its virulence plasmid (Haneda et al., 2001) .
We undertook an investigation of the bacterial component(s) involved in the serum-resistance phenotype of S. enterica serovar Choleraesuis, and found that an outermembrane protein, PagC, when expressed in E. coli, conferred a high level of serum resistance upon the bacteria, which was equal to that conferred by the wild-type Rck. Furthermore, in contrast to the wild-type parental strain, an isogenic pagC mutant showed a decrease in serum resistance. The results of this study provide direct evidence that, although PagC does not possess the functional activity of serum resistance (Heffernan et al., 1994) , it is an important surface component of S. enterica serovar Choleraesuis required for escape from host complementmediated killing.
METHODS
Bacterial strains and culture conditions. The bacterial strains and plasmids used in this study are listed in Table 1 . All strains were incubated at 37 uC in Luria-Bertani (LB) broth, with gentle shaking. When appropriate, antibiotics were used at the following concentrations: ampicillin at 100 mg ml
21
, kanamycin at 25 mg ml 21 , rifampicin at 50 mg ml 21 and spectinomycin at 50 mg ml 21 .
Construction of plasmids. The gene rck was PCR-amplified from the purified 94 kb plasmid DNA of S. enterica serovar Typhimurium strain SL1344 (Hoiseth & Stocker, 1981 ) using primers harbouring restriction sites (underlined), rck-1 (59-CGGGATCCATGAAGCGG-CGTTACGGG-39) and rck-2 (59-ACGCGTCGACATATCTGACCG-GGAGCG-39), and the PCR product was cloned into the pBR322 using BamHI and SalI to create prck. The genes pagC and waaG were amplified from S. enterica serovar Choleraesuis strain RF-1 chromosome using pagC-1 (59-CGGGATCCGATGACATTGTAGA-ACCGG-39) and pagC-2 (59-ACGCGTCGACACTGGTAAAGAAGC-CCTG-39), or waaG-1 (59-AGGCAGATGTTAAAGCCGCT-39) and waaG-2 (59-CGCTCACAGTCGATTAGGTA-39), and the PCR products were cloned into the TA cloning vector pGEM-T Easy (Promega) to generate pGEM-pagC and pGEM-waaG, respectively. The SphI-SalI fragments of pGEM-pagC and pGEM-waaG were ligated with the same sites of pACYC184 and pMW118 to produce ppagC and pwaaG, respectively. pGEM-pagC1 was generated by insertion of a 2?0 kb SmaI fragment of the V interposon from pHP45V (Fellay et al., 1987) , which contains a streptomycin/spectinomycin-resistance gene flanked by strong transcription and translation termination signals, at the blunted ClaI site of pGEM-pagC. pwaaG1 was produced by insertion of the SmaI-digested Km r -encoding gene (kan) cassette from pUC18K (Menard et al., 1993) at the EcoRV site of pGEM-waaG. The SphI-SalI fragment of pGEM-pagC1 was ligated with the same sites of plasmid pACYC184 to create ppagC1.
Mutations in PagC were made by reverse-PCR-based site-directed mutagenesis. The PCR product was generated by using a set of primers harbouring XbaI sites (underlined), pagC-MT1 (59-GG-TCTAGAAAGTACGGTTCTTTAATGGTTG-39) and pagC-MT2 (59-GGTCTAGAAAACTTGTCATGGTAATGAATA-39), designed to replace Glu at position 89 and Val at position 90 in the PagC peptide, with Ser and Arg, respectively. pGEM-pagC was used as a template. After gel purification using a Qiagen gel extraction kit, the PCR-amplified segment was digested with XbaI, self-ligated, and transformed into E. coli DH5a. Sequence analysis verified that the mutation was generated correctly. The SphI-SalI fragment of the resulting plasmid containing mutagenized DNA that encodes PagC E89S/V90R was ligated with the same sites of pACYC184 to produce ppagC2.
Construction of S. enterica serovar Choleraesuis mutants.
To construct pagC and waaG mutants of S. enterica serovar Choleraeusis strain RF-1, a NotI fragment of pGEM-pagC1 containing the pagC : : V allele or pGEM-waaG1 containing waaG : : kan was ligated with the same sites of the suicide vector pWM91 (Metcalf et al., 1996) , and the resulting plasmids were transferred from E. coli S17.1lpir to S. enterica serovar Choleraesuis strain RF-1 by conjugation. Exoconjugants were selected for sucrose resistance, and screened for ampicillin sensitivity, as described by Gotoh et al. (2003) and Metcalf et al. (1996) . Modifications on the chromosome were confirmed by PCR.
Construction of Salmonella serovar Choleraesuis genome DNA library and isolation of serum-resistant E. coli transformants. DNA from S. enterica serovar Choleraesuis strain RF-1 was partially digested by Sau3AI, and size-selected on a 5-20 % potassium acetate density gradient. Fractions containing DNA of 1-5 kb in size were purified and ligated into the BamHI site of the plasmid vector pBR322, and used to transform E. coli DH5a. To identify clones expressing serum resistance, a plasmid library prepared in E. coli DH5a was screened by a large-scale serum-killing assay. E. coli transformants grown on LB plates (~1000 c.f.u. per plate) were suspended in 5 ml PBS, harvested by centrifugation, and resuspended in 5 ml TGS medium [1 % (w/v) tryptone, 1 % (w/v) glucose and 30 % (v/v) swine serum]. After incubation for 1 h at 37 uC, bacteria were harvested by centrifugation, resuspended in 5 ml TGS medium, and incubated for a further 1 h at 37 uC. The serumresistant clones were then isolated on selective LB plates. Insertion of the chromosomal DNA into the pBR322 was confirmed by PCR using oligonucleotide primers PBR-1 (59-CTCTATCTACTACGC-GAT-39) and PBR-2 (59-ACCTGTGGCGCCGGTGAT-39). DNA sequencing of insert DNA was performed as described previously (Haneda et al., 2001) .
Serum sensitivity assay. Normal swine serum was collected, pooled, and stored at 280 uC until use. Normal human serum was obtained from Sigma-Aldrich. Control serum was heat inactivated for 30 min at 56 uC. For the serum killing assay, bacteria were grown to an OD 600 of 0?3, then 0?2 ml of the culture was removed and centrifuged for 2 min at 10 000 g. The bacterial pellet was then suspended in 1 ml PBS with 0?1 % gelatin, and the bacterial suspension (500 ml), containing 10 7 c.f.u., was added to the same volume of swine serum (final concentration 50 %). Samples were obtained at 0, 5, 15 and 30 min after incubation at 37 uC, and the number of viable bacteria was calculated by serial dilution and plating on LB agar.
Antibody production. To obtain polyclonal antibody against PagC protein, rabbits were immunized with PagC-peptide, encompassing amino acid residues 32-46 (YAQSKVQDFKNIRGV), in accordance with the institutional guidelines for animal housing and handling. The IgG fraction specific for PagC peptide was separated from immunized sera with PagC-peptide-conjugated epoxy-activated Sepharose 6B (Amersham Pharmacia Biotech).
Outer membrane preparation, SDS-PAGE and Western blotting.
Triton-X-100-insoluble outer membranes were isolated from E. coli and Salmonella strains according to the method described by Heffernan et al. (1992a) . Protein concentrations were determined by use of a Micro BCA protein assay kit (Pierce Biotechnology), with BSA as a standard. Equal amounts of protein were subjected to SDS-PAGE in 15 % polyacrylamide gel, under reducing conditions. For immunostaining of PagC protein, proteins were transferred to a PVDF membrane (Immobilon; Millipore), and labelled with rabbit anti-PagC antiserum diluted at 1 : 1000, and alkaline-phosphataseconjugated goat anti-rabbit IgG antibody (Sigma-Aldrich) diluted at 1 : 5000, as described previously (Miki et al., 2004) .
Detection of surface-exposed PagC protein by confocal laser microscopy. E. coli strains expressing PagC and mutant PagC proteins were grown overnight in LB broth. Bacteria were fixed with 1?0 % formaldehyde in PBS for 10 min, and then washed three times in PBS. Fixed bacteria were incubated with antibody against PagC (1 : 1000) for 1 h at room temperature, and unbound antibody was removed by washing in PBS containing 0?05 % Tween 20 (PBST). The pellet was suspended in Alexa-Fluor-488-conjugated anti-rabbit IgG antibody diluted in 1 : 500 (Molecular Probes). The suspension was then spotted on poly-L-lysine-coated microscope slides, and mounted with Vectashield mounting medium (Vector Laboratories) containing 49,69-di-amidino-2-phenylindole (DAPI; Molecular Probes). Samples were analysed by confocal laser microscopy (model LSM510 META; Carl Zeiss).
Whole-cell ELISA. To provide quantitative information on the surface-exposed PagC protein of E. coli and Salmonella strains, a whole-cell ELISA was carried out. Briefly, bacteria grown to an OD 600 of 0?5 were removed and centrifuged for 2 min at 10 000 g. The bacterial pellet was then suspended in 1 ml 50 mM carbonate buffer (pH 9?5), and the bacterial suspension (100 ml) containing 10 8 c.f.u. was coated onto the wells of a 96-well ELISA plate at 4 uC overnight. The wells were then washed, and excess binding sites were blocked with 2 % BSA in PBS containing 0?02 % sodium azide. Rabbit anti-PagC antibody (1 : 1000), the primary antibody, was then incubated in the wells for 2 h at 37 uC. Following three washes with PBST, alkaline-phosphatase-conjugated goat anti-rabbit IgG antibody (1 : 5000) was added to each well, and incubated for 1 h at 37 uC. After extensive washing with PBST, substrate (p-nitrophenyl phosphate; Sigma-Aldrich) was prepared at 1 mg ml 21 in 1 M diethanolamine buffer (pH 9?8) containing 0?5 mM MgCl 2 , and added to the wells for 30 min. The absorbance at 405 nm was then measured using an ELISA plate reader (Ultrospec visible plate reader II; Amersham-Pharmacia-Biotech).
RESULTS
Isolation of the genetic region responsible for serum resistance in S. enterica serovar Choleraesuis
To identify the gene(s) associated with serum resistance activity in S. enterica serovar Choleraesuis, a chromosomal gene library was made in E. coli DH5a, a strain that is quite sensitive to serum killing, from S. enterica serovar Choleraesuis strain RF-1. E. coli transformants carrying the chimeric plasmid DNAs were screened for their serum resistance phenotype. From a total of~10 000 transformants tested, 12 clones were identified that expressed serum resistance. PCR-amplification of inserted DNA fragments from 12 of these chimeric plasmids demonstrated that all of them contained a 3?6 kb DNA fragment of the S. enterica serovar Choleraesuis chromosome. In addition, restriction enzyme analysis revealed that 12 of these chimeric plasmids were identical. Thus, only one of these 12 clones, plasmid pMK1 (Fig. 1) , was chosen for further detailed characterization. Characterization of the pagC region of S. enterica serovar Choleraesuis A series of chimeric plasmids were constructed to determine the minimal DNA region required for serum resistance in E. coli DH5a (Fig. 1) . To determine the serum resistance of E. coli transformants harbouring these plasmids, the kinetics of bacterial viability in swine serum was measured (Fig. 2) . Plasmids pBR322 and prck were used for negative and positive controls, respectively. These data suggested that the 0?8 kb PstI-BglII fragment present in pMK6 was sufficient to make the bacteria serum resistant. Furthermore, insertional mutagenesis of the 1?6 kb PstI-EcoRI fragment, using an V element containing the kanamycin resistance gene (VKm2), showed that insertion into the ClaI site (pMK7), but not the BglII site (pMK8), abolished expression of the serum resistance activity of E. coli transformants, confirming the above results. Since inactivation of complement by heating at 56 u C for 30 min prior to bacterial inoculation permitted survival to the same extent as in PBS only, the bacterial killing by swine serum appeared to be mediated by the complement system.
To further analyse the chromosomal region related to serum resistance in S. enterica serovar Choleraesuis, a 3?6 kb DNA fragment in pMK1 was sequenced. A homology search of the DNA database revealed that the 3584 bp DNA segment from S. enterica serovar Choleraesuis chromosome corresponded to that of bp 1 332 185-1 335 769 in the S. enterica serovar Typhimurium LT2 complete genome sequence (McClelland et al., 2001) , which contains the five ORFs (STM1246-STM1250) and one truncated ORF (STM1251) (Fig. 1) . A 558 bp coding region (STM1246, corresponding to pagC) between the PstI and BglII sites was identified as the minimal region necessary to confer serum resistance upon E. coli. The predicted amino acid sequence of PagC from S. enterica serovar Choleraesuis exhibited 100 % identity to the PagC from S. enterica serovar Typhimurium LT2 (McClelland et al., 2001) , and 96 % identity (98 % homology) to the PagC from S. enterica serovar Typhi CT18 (Parkhill et al., 2001) . Heffernan et al. (1994) showed that PagC did not confer attachment, invasion or serum resistance. Thus, to examine whether expression of PagC on the outer membrane in E. coli DH5a could be responsible for the serum resistance phenotype, outer-membrane fractions, which had been partially purified by the treatment of whole cells with Triton X-100, were isolated and analysed for the presence of PagC by Western blotting, using an antibody specific for PagC. As shown in Fig. 3 , a 17?8 kDa immunoreactive protein corresponding to the molecular mass of mature PagC was detected from E. coli harbouring pMK1, pMK3, pMK6 and pMK8, which showed serum resistance, but not from E. coli carrying pMK2, pMK4, pMK5 and pMK7, which showed serum sensitivity. The same results were obtained from E. coli strains containing ppagC with a cloned intact pagC gene, and ppagC1 with a pagC gene inactivated by V insertion (pagC : : V) (data not shown).
These results strongly suggest that the serum resistance phenotype is conferred upon E. coli by expression of the outer-membrane protein PagC. Furthermore, since Heffernan et al. (1994) , using E. coli strain HB101 and human serum, showed that cloned pagC does not encode a serum resistance phenotype, plasmid ppagC was transformed into E. coli strain HB101, and the transformant was tested for viability in normal human serum. As when expressing Rck, E. coli HB101 expressing PagC also exhibited serum resistance (Fig. 2b) . Thus, the discrepancy between this and other studies regarding PagC function is not due to differences in the E. coli strain and the source of the serum.
Serum resistance phenotype of PagC mutated in the surface-exposed loop 2 region PagC protein belongs to a family of outer-membrane proteins containing eight transmembrane b strands, and is highly homologous to Rck from S. enterica serovar Typhimurium, and Ail from Yersinia enterocolitica (Fig. 4a) . Site-directed mutagenesis of Ail has revealed that amino acid residues Asp-68 and Val-69, in the C-terminal end of the second surface-exposed domain (loop 2), are active sites for serum resistance (Miller et al., 2001) . Therefore, to test whether the functional region of PagC for serum resistance is similar to the homologous protein Ail, we constructed a mutant PagC protein (PagC E89S/V90R ) in which Glu-89 and Val-90, corresponding to Asp-68 and Val-69 in Ail, were replaced with Ser and Arg, respectively. The mutant PagC containing double point mutations expressed by E. coli was detected in whole-cell extract at the same level as the wild-type PagC (data not shown). In addition, the amount of PagC E89S/V90R in Triton-X-100-insoluble membrane fractions analysed by immunoblotting, using a rabbit anti-PagC antibody, was found to be similar to the wild-type level, suggesting that PagC E89S/V90R is correctly located in the outer membrane (Fig. 5a) . The surface expression of the PagC mutant protein was further confirmed quantitatively by whole-cell ELISA and immunofluorescence microscopy (Fig. 5b, c) . Although the mutations in PagC did not affect the amount of PagC produced, or its proper location in the membrane, E. coli expressing mutant PagC E89S/V90R (ppagC2) showed complete loss of the serum resistance phenotype (Fig. 6) . Thus, it is likely that the amino acid residues (Glu-89 and Val-90) in loop 2 (see Fig. 4b ) are important for the function of the PagC protein.
PagC is a determinant of bacterial resistance to serum complement in Salmonella serovar Choleraesuis
To further demonstrate whether the pagC gene is an important determinant of resistance to the host complement in S. enterica serovar Choleraesuis, we constructed an isogenic S. enterica serovar Choleraesuis pagC mutant strain, MK100, and compared its serum resistance activity with that of the wild-type strain RF-1, which was found to be highly resistant to serum-mediated killing. The surface Fig. 2 . Serum sensitivity assay for E. coli strains carrying the plasmid pMK1 and its derivatives. (a) E. coli DH5a strains containing pMK1 and its derivatives were tested for viability in swine serum. (b) E. coli HB101 strains containing pBR322 and ppagC were tested for viability in human serum. Bacteria grown to mid-exponential phase were incubated at 37 6C in 50 % serum ($) or heat-inactivated serum (&).
expression of PagC protein in these strains was examined by Western blotting (Fig. 7a) . As shown in Fig. 7(b) , the pagC mutant strain MK100 could survive exposure to 50 % swine serum for 30 min; thereafter, the number of viable bacteria decreased, reaching less than 90 % of the inoculated dose at 60 min, whereas the wild-type RF-1 continued to show serum resistance at the same time point. Introduction of the intact pagC gene in plasmid ppagC to strain MK100 (strain MK101) restored the serum resistance to the wildtype level (Fig. 7b) , but the vector alone had no effect (data not shown). In addition, no bactericidal activity was observed when these bacteria were incubated with heatinactivated swine serum, as expected (data not shown).
We next tested the growth of S. enterica serovar Choleraesuis strains RF-1 and MK100 (pagC : : V) with TGS medium containing 30 % swine serum. Bacteria cultured at 37 uC without shaking were removed at regular intervals, and the OD 600 was measured. The wild-type strain RF-1 grew at similar rates in TGS medium containing either serum or heat-inactivated serum, whereas the growth rate of the mutant strain decreased as compared with that of the wildtype strain (Fig. 7c) . The growth rate in strain MK101 was similar to that of the wild-type strain (data not shown). These results suggested that pagC inactivation altered the serum resistance activity of S. enterica serovar Choleraesuis.
Since the LPS O-antigen has been implicated as a major determinant of the serum resistance of Salmonella (Grossman et al., 1990; Joiner et al., 1986; Murray et al., 2003; Tomas et al., 1988) , the effect of pagC expression on the serum resistance of rough S. enterica serovar Choleraesuis strains was examined. The PagC expression of these strains was measured by immunoblotting and whole-cell ELISA using a rabbit anti-PagC antibody (Fig. 8a, b) . The rough LPS mutant MK200 (waaG : : kan), which lacks an outer core region and O-antigen chains of LPS, showed a marked decrease in survival upon incubation with swine serum, although the level of PagC expression in its outer membrane was similar to that of the wild-type (Fig. 8a, b) . Complementation with an intact waaG gene on the plasmid (pwaaG) restored the LPS structure as well as the serum resistance phenotype of the mutant strain MK200. Interestingly, overexpression of pagC by introduction of plasmid ppagC caused a marked increase in the serum resistance of the rough mutant MK200 (Fig. 8c) . These results indicate that PagC plays an important role in the resistance of S. enterica serovar Choleraesuis to the bactericidal activity of serum complement. In addition, the waaG and pagC double mutant strain MK203 showed increased susceptibility to serum complement compared with the waaG single mutant strain MK200 at 60 min after incubation (Fig. 8c) , indicating that the serum resistance activity encoded by pagC is expressed independently of the LPS structure.
DISCUSSION
Resistance to complement-mediated killing or serum resistance is an important virulence determinant in Gramnegative bacteria. In this study, we found that the pagC gene of S. enterica serovar Choleraesuis chromosome confers a high level of resistance to the bactericidal activity of pooled normal swine serum when cloned into E. coli or Salmonella strains. In addition, insertion and deletion mutations of the cloned pagC gene abolished serum Triton-X-100-insoluble outer membranes were isolated from E. coli strains, and equal amounts of protein (10 mg per lane) were separated in 15 % polyacrylamide gels by SDS-PAGE.
Proteins were transferred to a PVDF membrane, and probed with affinity-purified rabbit anti-PagC antibody. resistance in the host strains. pagC is a phoPQ-regulated gene required for intramacrophage survival and virulence of Salmonella in a mouse infection model (Miller et al., 1989) . PagC belongs to a family of 17-19 kDa outer-membrane proteins that are predicted to have eight membranespanning amphipathic b-strands and four loops (Heffernan et al., 1992a) , i.e. Rck (S. enterica serovar Typhimurium), Ail (Y. enterocolitica), OmpX (Enterobacter cloacae), Lom (bacteriophage l) and Omp4 (Serratia marcescens). Despite the high level of homology among these outer-membrane proteins, they appear to be functionally distinct. While Rck and Ail share similar phenotypes that confer serum resistance, and attachment and invasion to tissue culture cells (Bliska & Falkow, 1992; Heffernan et al., 1994; Pierson & Falkow, 1993) , expression of OmpX and Lom has no effect on these virulence-associated phenotypes (Heffernan et al., 1994) . In contrast to the present findings, Heffernan et al. (1994) reported that PagC does not confer attachment, invasion or serum resistance. However, we found that a cloned pagC gene was able to promote resistance to complement-mediated lysis. Since both our study and that of Heffernan et al. (1994) used pBR322-based constructs in the same E. coli strain, and the same source of serum to assess the serum sensitivity, the reason for the discrepancy remains unclear. Recently, consistent with the high sequence similarity between the predicted extracellular loops of Rck and PagC, a conserved role of both proteins in binding to host tissue mediated by the extracellular matrix component laminin has been reported (Crago & Koronakis, 1999) .
The lack of a common function shared among the members of this family of outer-membrane proteins has been Triton-X-100-insoluble outer-membrane fractions from E. coli strains carrying ppagC, ppagC2 or pBR322 was performed by using affinity-purified rabbit anti-PagC antibody as described in Fig. 3 attributed to the fact that the membrane-spanning regions are homologous , while the cell-surface domains, which appear to determine the specificity of bacteria-host-cell interactions, show higher levels of sequence divergence . Recently, Miller S. enterica serovar Choleraesus strains RF-1 (wild-type), MK200 (waaG : : kan), MK201 (MK200/pwaaG) and MK202 (MK200/ppagC) was performed by using a rabbit anti-PagC antibody. (b) S. enterica serovar Choleraesuis strains RF-1 (wild-type), MK 100 (pagC : : V), MK200 (waaG : : kan), MK201 (MK200/pwaaG) and MK202 (MK200/ppagC) were grown to mid-exponential phase, and coated on the wells of a 96-well plate. Surface expression of PagC protein was then examined by an ELISA using an affinity-purified rabbit anti-PagC antibody. The data are means±SD of triplicate samples. (c) Serum sensitivity assay for S. enterica serovar Choleraesuis strains RF-1 (wild-type; $), MK200 (waaG : : kan; &), MK201 (MK200/ pwaaG; m), MK202 (MK200/ppagC; #) and MK203 (pagC : : V waaG : : kan; %). Bacteria grown to mid-exponential phase were incubated at 37 6C in 50 % swine serum.
et al. (2001) determined the functional domain of Ail required for the invasion and serum resistance phenotypes. Analysis of the insertion, deletion and point mutations in the surface-exposed loops of Ail revealed that the second cell-exposed domain (loop 2), contains a sequence required for Ail function, and the first and fourth cell surface domains (loops 1 and 4) are not directly responsible for Ailmediated phenotypes. In addition, D67G and V68G, the double point mutations in the C-terminal end of loop 2, completely eliminated both the serum resistance and invasion phenotypes. Consistently, the double mutations in the C-terminal end of the second cell-surface domain of PagC caused loss of serum resistance, demonstrating that a specific amino acid sequence in the second cell-surfaceexposed domain is critical for the interaction of the protein with the complement components. Furthermore, in a study comparing the chimeric proteins Rck and PagC, Cirillo et al. (1996) showed that replacement of the Cterminal-half containing loops 3 and 4 of Rck with the corresponding region of PagC abolished the ability of Rck to confer serum resistance, while replacement of loop 4 alone had no effect on serum resistance. Thus, the third cell-surface-exposed domain of Rck is involved in the protein function (Cirillo et al., 1996) . These data may also indicate that the third and fourth loops of PagC are not associated with PagC-mediated serum resistance.
In conclusion, although the basis of the serum resistance phenotype of PagC has not yet been elucidated, we have shown that the pagC gene from the S. enterica serovar Choleraesuis chromosome confers upon E. coli and Salmonella strains the ability to grow in swine serum at a rate comparable to their growth in control heat-inactivated serum. Interestingly, S. enterica serovar Typhimurium, but not serovar Choleraesuis, maintains two outer-membrane proteins that are responsible for serum resistance: Rck, encoded on the virulence plasmid, and PagC, encoded on the chromosome. Therefore, the conservation of the two copies of these proteins may be of selective advantage to S. enterica serovar Typhimurium, which has a wider range of host specificity than serovar Choleraesuis, because it offers an increased opportunity of survival during systemic infection of its host.
